Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases

Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases

Background. In Mexico, asthma is one of the top twenty causes of disease with 254,713 new cases reported in 2019. According to Phase 3 of the International Study of Asthma and Allergies in Childhood, the prevalence of asthma ranged from 5 to 14% in 6 Mexican cities with varied geographic conditions...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Maria del Carmen Cano Salas, José Luis Miguel Reyes, Karen Sánchez Trejo, Erika del Carmen López Estrada, Jorge Salas Hernández, Monserrat Evelia Arroyo Rojas, Mauricio Castañeda Valdivia, Monserrat Escobar Preciado, Silvia Guzmán Vázquez, Sergio Ricardo García-García, Herman Soto Molina
التنسيق: مقال
اللغة:English
منشور في: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2024-04-01
سلاسل:Revista Alergia México
الموضوعات:
Adverse reaction to the drug
الوصول للمادة أونلاين:https://revistaalergia.mx/ojs/index.php/ram/article/view/1279

مواد مشابهة

مواد مشابهة